Mario Ferraioli
Overview
Explore the profile of Mario Ferraioli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
62
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ferraioli M, Levani J, De Luca R, Matucci-Cerinic C, Gattorno M, Guiducci S, et al.
J Clin Med
. 2025 Feb;
14(4).
PMID: 40004896
Synovitis-acne-pustulosis-hyperostosis-osteitis (SAPHO) syndrome is a rare disease characterized by a sterile inflammatory osteitis and/or arthritis associated with a wide range of dermatological manifestations, such as acne, palmoplantar pustulosis, and psoriasis....
2.
Fatica M, Cela E, Ferraioli M, Costa L, Conigliaro P, Bergamini A, et al.
J Pers Med
. 2024 Dec;
14(12).
PMID: 39728027
Spondyloarthritis (SpA) is a group of chronic inflammatory diseases affecting the spine and peripheral joints, causing pain, stiffness, and reduced mobility. This narrative review examines how lifestyle factors-specifically smoking, alcohol...
3.
Ramonda R, Lorenzin M, Chimenti M, Atzeni F, Semeraro A, DAngelo S, et al.
Arthritis Res Ther
. 2024 Sep;
26(1):172.
PMID: 39342310
Objectives: to evaluate over a 48-month follow-up period the: 1) long-term effectiveness and safety; 2) drug retention rate (DRR); 3) impact of comorbidities and bDMARDs line on MDA and DAPSA...
4.
Ramonda R, Lorenzin M, Chimenti M, DAngelo S, Marchesoni A, Selmi C, et al.
Front Immunol
. 2024 Jul;
15():1435599.
PMID: 39076975
Objectives: This study aims to evaluate in a real-life Italian multicenter cohort of axial spondyloarthritis (axSpA) (1) the 4-year effectiveness and safety of secukinumab, (2) the drug retention rate (DRR),...
5.
Caso F, Fatica M, Ferraioli M, Megna M, Potestio L, Ruggiero A, et al.
Expert Opin Biol Ther
. 2024 Jul;
24(8):719-731.
PMID: 39037828
Introduction: Psoriatic arthritis (PsA) is an immune-inflammatory disease that affects both joints and entheses, and with diverse extra-articular manifestations (psoriasis, inflammatory bowel disease (IBD), and uveitis). A wide range of...
6.
Ferraioli M, Fiannacca L, Greco E, Cela E, Fatica M, Bergamini A, et al.
Case Reports Immunol
. 2024 Mar;
2024:9076852.
PMID: 38533274
SAPHO syndrome is a complex disease that encompasses both inflammatory arthritis and/or osteitis and dermatologic manifestations. It is considered a rare disease, in fact, no clinical trials have been conducted...
7.
Conigliaro P, DAntonio A, Wlderk A, Sabuzi F, Ferraioli M, Sichi L, et al.
Ther Adv Chronic Dis
. 2024 Feb;
15:20406223241229843.
PMID: 38380226
Background: Enteropathic spondyloarthritides (eSpAs) are chronic inflammatory joint diseases associated with inflammatory bowel disease (IBD). Limited data are available on the prevalence since arthritis in IBD patients may be underestimated...
8.
Perrotta F, Scriffignano S, Triggianese P, Ferraioli M, Chimenti M, Lubrano E
J Rheumatol
. 2023 Dec;
51(3):257-262.
PMID: 38101911
Objective: The aim was to evaluate the sex differences in sensitivity, specificity, positive and negative predictive values, and likelihood ratio of the outcome indices minimal disease activity (MDA), Disease Activity...
9.
Picchianti-Diamanti A, Navarra A, Aiello A, Lagana B, Cuzzi G, Salmi A, et al.
Vaccines (Basel)
. 2023 Nov;
11(11).
PMID: 38006015
: We aimed to analyse the incidence and severity of breakthrough infections (BIs) in rheumatoid arthritis (RA) patients after a COronaVIrus Disease 2019 (COVID-19) vaccination booster dose. : We enrolled...
10.
Scriffignano S, Perrotta F, Conigliaro P, Ferraioli M, Triggianese P, Chimenti M, et al.
Rheumatol Ther
. 2023 Sep;
10(6):1785-1794.
PMID: 37715916
Introduction: The aim of this work is to characterize which Minimal Disease Activity (MDA) domains are mainly achieved, based on different treatments, in psoriatic arthritis (PsA) patients. Moreover, the association...